Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Bacampicillin is an ampicillin prodrug used to treat various susceptible bacterial infections in the body, such as respiratory infections and skin and subcutaneous tissue infections. It is absorbed following oral administration.
- Mechanism
- Curator reviewed
During absorption from the gastrointestinal tract, bacampicillin is hydrolyzed by esterases present in the intestinal wall. It is microbiologically active as ampicillin, and exerts a bactericidal action through the inhibition of the biosynthesis of cell wall mucopeptides.
- Primary indication
- For infections at the following sites: upper and lower respiratory tract; skin and soft tissue; urinary tract and acute uncomplicated gonococcal urethritis, when due to sensitive strains of the following organisms: Gram-positive: streptococci (including S....Curator reviewed · 9 structured indications
- Formula / weight
- C21H27N3O7S · 465.52 g/mol (avg)
- First approval
- Canada, 2000
Resolves to
PFOLLRNADZZWEX-FFGRCDKISA-NSMILES[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OC(C)OC(=O)OCCWhat you can answer from here — as of September 23, 2026
Which other approved drugs treat the same conditions as Bacampicillin, and which companies have late-stage candidates in those indications?